Explore evidence

37 yearsThe mean age of the 2652 TB/HIV co-infected participants was 37 ± 14 years.

Nigeriatuberculose · VIH/sidapublished 2024The Pan African medical journalPubMeddocument of 5 observations

0.14 hazard_ratioParticipants with viral loads less than 1000 copies/ml had a hazard ratio of 0.14 for loss to follow-up compared to those with higher viral loads.

NigeriaVIH/sidapublished 2025PloS onePubMeddocument of 8 observations

80.5 %Among 5928 persons living with HIV who initiated antiretroviral therapy with at least 6-month follow-up and one CD4 measurement, 3468 (80.5%) received nevirapine-based regimens.

NigeriaVIH/sidapublished 2020AIDS research and therapyPubMeddocument of 12 observations

11.42 per_1000_person-yearsFrom 2013 through 2020, the all-cause mortality rate among people living with HIV in the African Cohort Study was 11.42 deaths per 1000 person-years.

NigeriaVIH/sidaobserved 2013 through 2020published 2022Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 6 observations

21.8 %Among 1,168 participants enrolled from March to November 2024, 21.8% were living with HIV.

NigeriaVIH/sidaobserved March to November 2024published 2026The international journal of tuberculosis and lung disease : the official journal of the IPubMeddocument of 5 observations

150,191 patientsAmong patients enrolled on antiretroviral therapy from 2004 to 2017, 150,191 (61.2%) remained on treatment.

NigeriaVIH/sidaobserved 2004 to 2017published 2019AIDS research and therapyPubMeddocument of 11 observations

341 cells/mm³The participants' CD4 count ranged from 13 to 1338 cells/mm³, with a median count of 341 cells/mm³.

NigeriaVIH/sidapublished 2021The Pan African medical journalPubMeddocument of 6 observations

21 %Among 198 patient-derived samples sequenced during virologic failure, 42 (21%) were wild-type.

NigeriaVIH/sidapublished 2020AIDS research and therapyPubMeddocument of 12 observations

1,900,000 inhabitantsNigeria has 1.9 million HIV-positive residents.

NigeriaVIH/sidapublished 2024Contemporary clinical trialsPubMeddocument of 2 observations

90 %Three-month retention for monthly treatment initiation cohorts in the ART Surge improved to 90% over 6 months.

NigeriaVIH/sidapublished 2021PloS onePubMeddocument of 13 observations

95.2 %Transmission risk perception was 95.2% among mothers living with HIV and 65.3% among controls of unknown HIV status.

NigeriaVIH/sidapublished 2021Current HIV researchPubMeddocument of 2 observations

19 %Across Indonesia, Laos, Nepal, and Nigeria, between 19% and 51% of eligible clients were served by antiretroviral home delivery during the COVID-19 pandemic.

NigeriaVIH/sidapublished 2021Global health, science and practicePubMed

2.1 %The frequency of APOL1 high-risk genotype varied by ethnic group: Hausa/Fulani (2.1%), Igbo (49.1%), and Yoruba (14.5%).

NigeriaVIH/sidapublished 2021Kidney internationalPubMeddocument of 7 observations

58 %58% of 1342 participants were living with HIV.

NigeriaVIH/sidapublished 2020PloS onePubMeddocument of 4 observations

65 %Among nursing mothers living with HIV/AIDS in Port Harcourt, Nigeria, 65% adhered to the exclusive breastfeeding (EBF) policy guidelines.

NigeriaVIH/sidaobserved 2022published 2025The Pan African medical journalPubMeddocument of 3 observations

10.7 %Enacted stigma was reported by 10.7% of respondents.

NigeriaVIH/sidapublished 2022The Pan African medical journalPubMeddocument of 12 observations

76 %Three-month retention for monthly treatment initiation cohorts in the ART Surge improved from 76% to 90% over 6 months.

NigeriaVIH/sidapublished 2021PloS onePubMeddocument of 13 observations

34 yearsThe median age of the studied patients was 34 years.

NigeriaHIV/HBV · VIH/sidapublished 2019The Journal of antimicrobial chemotherapyPubMeddocument of 8 observations

1.356 odds_ratioThe unadjusted odds ratio of undetected viral load (≤20 copies/ml) was 1.356.

NigeriaVIH/sidapublished 2021The Journal of adolescent health : official publication of the Society for Adolescent MediPubMeddocument of 4 observations

75,041 patientsAmong patients enrolled on antiretroviral therapy from 2004 to 2017, 75,041 (30.6%) had a loss to follow-up event captured.

NigeriaVIH/sidaobserved 2004 to 2017published 2019AIDS research and therapyPubMeddocument of 11 observations

79.95 g/m²Left ventricular mass index was significantly higher in HIV-positive subjects on HAART (79.95).

NigeriaVIH/sidapublished 2021Cardiovascular journal of AfricaPubMeddocument of 9 observations

95 %Among HIV-1 infected individuals with plasma viral load (PVL) ≤40 copies/mL, EBNA IgG seropositivity was 95.0%.

NigeriaVIH/sida · virus Epstein-Barrpublished 2020Journal of immunoassay & immunochemistryPubMeddocument of 15 observations

36.1 %Among men who have sex with men (MSM) who reported sexual violence, 36.1% tested HIV positive.

NigeriaVIH/sidaobserved 2020published 2025AIDS and behaviorPubMeddocument of 6 observations

77 %77% of clients were willing to participate in community pharmacy HIV testing services (HTS).

NigeriaVIH/sidaobserved 2019published 2021International journal of STD & AIDSPubMeddocument of 11 observations

25 %Treatment mortality among HIV-infected, HIV-exposed infants in Shendam LGA, Plateau State, Nigeria was 25%.

NigeriaVIH/sidaobserved 2018–2022published 2026PloS onePubMeddocument of 13 observations